Plasmalemmal Vesicle Associated Protein (PLVAP) as a therapeutic target for treatment of hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is a malignancy with poor survival outcome. New treatment options for the disease are needed. In this study, we identified and evaluated tumor vascular PLVAP as a therapeutic target for treatment of HCC. METHODS: Genes showing extreme differential expressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yun-Hsin, Cheng, Tsung-Yen, Chen, Ta-Yuan, Chang, Kai-Ming, Chuang, Vincent P, Kao, Kuo-Jang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233082/
https://www.ncbi.nlm.nih.gov/pubmed/25376302
http://dx.doi.org/10.1186/1471-2407-14-815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233082/
https://www.ncbi.nlm.nih.gov/pubmed/25376302
http://dx.doi.org/10.1186/1471-2407-14-815

Ejemplares similares